| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.35 | 0.04 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |